TMCnet News
Navidea Biopharmaceuticals to Present at 2014 Biotech Showcase™ ConferenceDUBLIN, Ohio --(Business Wire)-- Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr. Mark Pykett, VMD PhD, Navidea Chief Executive Officer, and other members of Navidea management will participate in the 2014 Biotech Showcase Conference from January 13-15, 2014 held at the Parc 55 Wyndham-Union Square in San Francisco, CA (News - Alert). Dr. Pykett will provide an update of the Company and its commercial and development programs on Monday, January 13, 2014 at 11:00 AM PST in the Powell Room. Investors and the public are invited to listen to a live webcast of Dr. Pykett's presentation at http://www.media-server.com/m/p/etqv5fpu. Following the conference, the webcast will be archived for approximately 30 days.
About Navidea Biopharmaceuticals, Inc. |